ROYCE & ASSOCIATES LP - SELECT MED HLDGS CORP ownership

SELECT MED HLDGS CORP's ticker is SEM and the CUSIP is 81619Q105. A total of 210 filers reported holding SELECT MED HLDGS CORP in Q4 2020. The put-call ratio across all filers is 4.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of SELECT MED HLDGS CORP
ValueSharesWeighting
Q3 2023$8,259,297
-22.6%
326,842
-2.4%
0.08%
-19.2%
Q2 2023$10,666,409
+0.6%
334,790
-18.4%
0.10%
-1.9%
Q1 2023$10,605,997
+3.3%
410,290
-0.8%
0.11%
-1.9%
Q4 2022$10,269,440
+9.9%
413,590
-2.2%
0.11%
+1.9%
Q3 2022$9,348,000
-12.1%
422,990
-6.0%
0.11%
-2.8%
Q2 2022$10,633,000
-0.9%
450,172
+0.6%
0.11%
+19.8%
Q1 2022$10,732,000
+13.8%
447,357
+39.4%
0.09%
+30.0%
Q4 2021$9,432,000
-28.2%
320,814
-11.7%
0.07%
-28.6%
Q3 2021$13,140,000
-38.4%
363,290
-28.0%
0.10%
-33.3%
Q2 2021$21,326,000
-8.7%
504,637
-26.3%
0.15%
-6.4%
Q1 2021$23,346,000
+86.4%
684,637
+51.2%
0.16%
+52.4%
Q4 2020$12,523,000
+30.1%
452,737
-2.1%
0.10%
-1.0%
Q3 2020$9,624,000
+44.6%
462,237
+2.3%
0.10%
+42.5%
Q2 2020$6,656,000
+19.5%
451,837
+21.7%
0.07%
-3.9%
Q1 2020$5,570,000
-44.3%
371,306
-13.3%
0.08%
-14.6%
Q4 2019$9,997,000
+32.8%
428,306
-5.7%
0.09%
+27.1%
Q3 2019$7,528,000
+8.7%
454,306
+4.1%
0.07%
+11.1%
Q2 2019$6,928,000
+19.4%
436,576
+6.0%
0.06%
+28.6%
Q1 2019$5,801,000
+16.2%
411,676
+26.6%
0.05%
+8.9%
Q4 2018$4,991,000
+257.3%
325,176
+328.2%
0.04%
+350.0%
Q3 2018$1,397,000
-6.7%
75,945
-8.0%
0.01%0.0%
Q2 2018$1,498,000
-26.1%
82,545
-29.8%
0.01%
-28.6%
Q1 2018$2,028,000
-18.7%
117,545
-16.8%
0.01%
-17.6%
Q4 2017$2,493,000
+5.1%
141,245
+14.3%
0.02%
+6.2%
Q3 2017$2,372,000
-14.2%
123,545
-31.4%
0.02%
-11.1%
Q2 2017$2,764,000
-7.1%
180,045
-19.2%
0.02%
-5.3%
Q1 2017$2,974,000
+49.6%
222,800
+48.5%
0.02%
+46.2%
Q4 2016$1,988,000
-15.9%
150,000
-14.3%
0.01%
-18.8%
Q3 2016$2,363,000
+8.7%
175,000
-12.5%
0.02%
+14.3%
Q2 2016$2,174,000
-6.8%
200,000
+1.3%
0.01%
-6.7%
Q1 2016$2,332,000
+3.0%
197,500
+3.9%
0.02%
+7.1%
Q4 2015$2,263,000
+27.9%
190,000
+15.9%
0.01%
+55.6%
Q3 2015$1,770,000
-20.6%
164,000
+19.3%
0.01%0.0%
Q2 2015$2,228,000
-24.9%
137,500
-31.2%
0.01%
-18.2%
Q1 2015$2,966,000
-58.7%
200,000
-59.8%
0.01%
-56.0%
Q4 2014$7,173,000
-13.7%
498,114
-27.9%
0.02%
-10.7%
Q3 2014$8,308,000
-49.7%
690,614
-34.7%
0.03%
-42.9%
Q2 2014$16,507,000
+1.7%
1,058,114
-18.8%
0.05%
+2.1%
Q1 2014$16,224,000
-0.4%
1,303,114
-7.1%
0.05%
+2.1%
Q4 2013$16,290,000
+40.6%
1,403,114
-2.2%
0.05%
+38.2%
Q3 2013$11,583,000
+4.5%
1,435,314
+6.2%
0.03%0.0%
Q2 2013$11,085,0001,351,8140.03%
Other shareholders
SELECT MED HLDGS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Camber Capital Management LP 3,400,000$85,9182.83%
Sivik Global Healthcare LLC 192,343$4,8612.46%
Hood River Capital Management LLC 2,170,285$54,843,1021.76%
Smith, Graham & Co., Investment Advisors, LP 412,415$10,421,7271.30%
Huber Capital Management LLC 172,117$4,349,3971.02%
CLOUGH CAPITAL PARTNERS L P 348,900$8,816,7030.95%
Capital Impact Advisors, LLC 22,226$561,6510.94%
ESSEX INVESTMENT MANAGEMENT CO LLC 188,056$4,752,1750.78%
ICON ADVISERS INC/CO 78,800$1,991,2760.49%
Foundry Partners, LLC 278,433$7,036,0020.44%
View complete list of SELECT MED HLDGS CORP shareholders